Pennsylvania HR528: A Resolution directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

What the bill says

A resolution Directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

From the introduced text, May 14, 2026:

A RESOLUTION Directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. WHEREAS, Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are immune- mediated disorders triggered by many different infections, such as streptococcal infections, which cause sudden and severe neuropsychiatric symptoms, including obsessive-compulsive behaviors, tics, anxiety, restricted eating, mood swings and cognitive deterioration; and WHEREAS, The true lifetime prevalence of PANS and PANDAS is not known and frequent misdiagnosis makes it difficult to estimate the number of people affected; and WHEREAS, Effective treatments for PANS and PANDAS, including antibiotics, anti-inflammatory therapies and intravenous immunoglobulin (IVIG), can lead to full recovery if administered promptly but patients often experience limited or delayed access to these treatments because of inconsistent insurance coverage and a shortage of knowledgeable health care providers; and WHEREAS, The Pennsylvania Rare Disease Advisory Council (PARDAC) serves as an advisory board to the General Assembly and other State and private agencies that provide services to or are charged with the care of individuals with rare diseases but has not yet issued specific resources or recommendations on PANS and PANDAS; and WHEREAS, A limited number of health care practitioners in this Commonwealth have specialized training in the diagnosis and treatment …

Read the full official text

Sponsors

• Jill Cooper (R, 55) · primary sponsor
• Timothy Briggs (D, 149)
• Eddie Pashinski (D, 121)
• Mandy Steele (D, 33)
• Struzzi II, James B. (R, 62)
• Timothy Brennan (D, 29)
• Craig Williams (R, 160)
• Brenda Pugh (R, 120)
• Lindsay Powell (D, 21)
• Tarik Khan (D, 194)

Latest actions

1. June 30, 2026: (Remarks see House Journal Page ), June 30, 2026
2. June 30, 2026: Adopted, June 30, 2026 (201-1)
3. June 17, 2026: Reported as amended, June 17, 2026
4. May 14, 2026: Referred to HEALTH, May 14, 2026

Votes

• House Floor: HR0528, RC 1287 (June 30, 2026): 201 yea, 1 nay, passed
• House Health: Report Bill As Amended (June 17, 2026): 26 yea, 0 nay, passed
• House Health: Adopt Amendment (June 17, 2026): 26 yea, 0 nay, passed

Common questions

What is HR528?

HR528 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): A Resolution directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

What does HR528 do?

In its own words: A resolution Directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

What is the status of HR528?

Passed both chambers as of June 30, 2026. Latest action: (Remarks see House Journal Page ), June 30, 2026 (June 30, 2026).

Who sponsored HR528?

Jill Cooper (R, 55), with 9 co-sponsors.

Where is the official record for HR528?

On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hr528